Cytokines, signaling and diseases - a pharmacologist's view.
The International Society for Interferon and Cytokine Research held their meeting Cytokines, Signaling and Diseases in Cairns, Australia, October 26-30, 2003. As there were often parallel sessions, this report discusses selected symposia: STAT as a target for the treatment of cancer, Innate immunity, SOCS and c-CBL: Negative regulation, Tumor immunity, CNS disease, Cellular therapy with adult stem cells and Drug development. There were also a large number of presentations linking the cytokines to cancer and other diseases (e.g., asthma, diabetes), and these are discussed. Presentations considering new therapeutic targets (BAFF, and interleukin-17, -21 and -31) are also considered.[1]References
- Cytokines, signaling and diseases - a pharmacologist's view. Doggrell, S.A. Drug News Perspect. (2004) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
